
Microvascular and cardiovascular outcomes according to renal function in patients treated with once-weekly exenatide: Insights from the EXSCEL trial
Author(s) -
M. Angelyn Bethel,
R.J. Mentz,
P. Merrill,
J.B. Buse,
J.C. Chan,
Smita Goodman,
N. Iqbal,
N. Jakuboniene,
B. Katona,
Y. Lokhnygina,
R.D. Lopes,
A.P. Maggioni,
P. Ohman,
T. Tankova,
G.L. Bakris,
A.F. Hernandez,
R.R. Holman
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/wd7y-wk80
Subject(s) - exenatide , medicine , renal function , intensive care medicine , cardiology , endocrinology , diabetes mellitus , type 2 diabetes